Nigeria, Cuba Signs Deal On Vaccine Production
Nigeria and Cuba have signed a contract manufacturing, technology transfer, vaccine production, and business expansion agreement for Cuban biopharmaceutical products.
Per the News Agency of Nigeria (NAN), Benaoyagha Okoyen, Nigeria’s ambassador to Cuba, said in a statement released in New York that both countries agreed to collaborate in other areas.
According to the envoy, Nigeria signed the agreement with Cuba at the recently concluded 2022 BioHabana International Conference, which took place in Havana from April 25 to 29.
The document was signed by Okoyen and Eduardo Diaz, president of the Biotechnological and Pharmaceutical Industries (BioCubaFarma), who represented the Republic of Cuba.
He stated that both countries expressed a desire to carry out actions to strengthen their partnership, particularly in projects involving scientific cooperation, academic collaboration, co-development agreements, and the licensing of innovative products.
“The Embassy of Nigeria in Havana, led by the Ambassador, played an important role in guiding the Nigerian delegation through the various stages of their participation in the conference, including the coordination of several relevant side meetings,” he said.
“The delegation included representatives from the Ministry of Health, the National Agency for Food, Drug Administration, and Control, the Federal Ministry of Science and Innovation, the Sheda Science and Technology Complex, the National Biotechnology Development Agency, Nnamdi Azikiwe University in Awka, and the West African Health Organization” (WAHO).
The conference’s facilitator, BioCubaFarma, is a Cuban government commercial enterprise and biotechnology corporation specializing in scientific and technological development, producing high-tech pharmaceuticals, equipment, and services.
No fewer than twelve countries, including Nigeria, Australia, Russia, Germany, Japan, Canada, South Korea, and Turkey, signed 18 agreements.
